Sale!

LMNA Gene Restrictive Dermopathy Lethal NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The LMNA Gene Restrictive Dermopathy Lethal NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the LMNA gene responsible for restrictive dermopathy, a rare and often fatal genetic disorder affecting skin, bone, and immune system development. This advanced next-generation sequencing test provides precise detection of genetic abnormalities that cause tight, rigid skin, joint contractures, and respiratory complications. Priced at $500 USD, the test is essential for families with a history of this condition or when characteristic symptoms are present in newborns. Early genetic diagnosis enables better medical management, informed family planning decisions, and access to specialized care. Our testing process includes genetic counseling to help interpret results and understand inheritance patterns.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

LMNA Gene Restrictive Dermopathy Lethal NGS Genetic DNA Test

Understanding Restrictive Dermopathy and the LMNA Gene

Restrictive dermopathy is an extremely rare and typically lethal genetic disorder characterized by tight, rigid skin that restricts normal movement and development. This condition represents one of the most severe forms of genetic skin disorders, often resulting in neonatal death due to respiratory complications and multiple organ system involvement. The LMNA gene plays a crucial role in maintaining nuclear structure and function, and mutations in this gene disrupt normal cellular processes, leading to the characteristic features of restrictive dermopathy.

What This Advanced Genetic Test Detects

Our LMNA Gene Restrictive Dermopathy Lethal NGS Genetic DNA Test utilizes cutting-edge Next-Generation Sequencing (NGS) technology to comprehensively analyze the LMNA gene for pathogenic mutations. This sophisticated testing approach identifies:

  • Point mutations affecting lamin A/C protein production
  • Frameshift mutations disrupting normal gene function
  • Nonsense mutations leading to premature protein termination
  • Splice site mutations affecting RNA processing
  • Deletions and insertions within the LMNA gene sequence

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals and families experiencing:

  • Newborns presenting with tight, shiny skin and restricted joint mobility
  • Families with a history of restrictive dermopathy or similar skin disorders
  • Prenatal cases showing ultrasound abnormalities suggestive of skin restrictions
  • Individuals with unexplained fetal loss and characteristic skin findings
  • Couples with previous affected children planning future pregnancies

Clinical Symptoms and Indicators

The following clinical features may indicate the need for LMNA gene testing:

  • Severe skin tightening and rigidity present at birth
  • Multiple joint contractures limiting movement
  • Facial features including micrognathia and pinched nose
  • Respiratory distress due to chest wall restrictions
  • Growth restriction and failure to thrive
  • Osteological abnormalities and bone development issues

Significant Benefits of Early Genetic Diagnosis

Undergoing LMNA gene testing provides numerous critical advantages:

  • Accurate Diagnosis: Confirms or rules out restrictive dermopathy with precision
  • Family Planning Guidance: Enables informed reproductive decisions for at-risk families
  • Medical Management: Helps guide appropriate palliative care and treatment approaches
  • Genetic Counseling: Provides comprehensive understanding of inheritance patterns
  • Research Contribution: Advances scientific knowledge about rare genetic disorders
  • Emotional Closure: Offers answers to families affected by this devastating condition

Understanding Your Test Results

Our genetic counseling team provides comprehensive interpretation of your LMNA gene test results:

  • Positive Result: Indicates the presence of a pathogenic LMNA mutation confirming restrictive dermopathy diagnosis
  • Negative Result: Suggests absence of detectable LMNA mutations, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results are accompanied by detailed explanations and recommendations for next steps from our certified genetic counselors.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing for families nationwide.

Take the Next Step Toward Genetic Clarity

If you suspect restrictive dermopathy or have a family history of this condition, don’t wait to get answers. Our experienced genetic specialists are ready to guide you through the testing process and provide the comprehensive care your family deserves.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and LMNA gene testing. Our compassionate team understands the emotional challenges of rare genetic disorders and is committed to providing supportive, expert care throughout your diagnostic journey.

Early genetic testing can provide crucial information for medical management and family planning decisions. Take control of your genetic health today.